Status:
COMPLETED
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics
Lead Sponsor:
Janssen-Cilag International NV
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this non-interventional, observational and international registry study is to document the prescribing patterns in daily clinical practice and to assess long term treatment outcomes rel...
Detailed Description
PILAR is a non-interventional, observational, international registry on the use of oral antipsychotics in a naturalistic setting in patients with schizophrenia. Patients initiating a new oral antipsyc...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia
- Switch to or start on paliperidone ER or another oral antipsychotic treatment (either atypical or conventional), not longer than 2 weeks ago
- Signed informed consent is available at the beginning of documentation
- Able and willing to fill-out self-administered questionnaires
Exclusion
- Established treatment-refractory schizophrenia
- History of neuroleptic malignant syndrome
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
3064 Patients enrolled
Trial Details
Trial ID
NCT00696813
Start Date
June 1 2008
End Date
January 1 2011
Last Update
February 5 2013
Active Locations (84)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria, British Columbia, Canada
2
Burlington, Ontario, Canada
3
Chatham, Ontario, Canada
4
Greater Sudbury, Ontario, Canada